C85.92 Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes
• ICD Code: C85.92

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in the intrathoracic lymph nodes (e.g., mediastinal, hilar, or intrapulmonary nodes). The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the chest or neck
• Persistent cough or chest discomfort
• Shortness of breath
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Difficulty swallowing (if nodes press on the esophagus)

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or PET scans) to identify intrathoracic lymph node involvement, and a biopsy of the affected nodes. Blood tests and bone marrow evaluation may also be performed to assess disease extent.

Treatment Options

Treatment depends on the subtype, stage, and patient health but may include chemotherapy, radiation therapy (targeting intrathoracic nodes), immunotherapy, or a combination of these. Stem cell transplantation may be considered for aggressive cases.

Prognosis and Follow-Up

Prognosis varies based on subtype, stage, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term survival is possible with appropriate therapy.

Complications

• Respiratory issues (e.g., airway compression, pleural effusion)
• Infection due to weakened immunity
• Metastasis to other organs
• Treatment-related side effects (e.g., fatigue, nausea)

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known carcinogens (e.g., tobacco, excessive alcohol).
• Manage chronic infections or immune disorders under medical guidance.

When to Seek Professional Help

Seek care if you experience persistent chest symptoms, unexplained weight loss, night sweats, or swollen lymph nodes. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use C85.92 when documenting non-Hodgkin lymphoma with unspecified subtype localized to intrathoracic lymph nodes. Ensure clinical documentation specifies the anatomical site (e.g., mediastinal, hilar) to support code assignment. Do not use this code if the subtype is identified or the site is outside the intrathoracic region.